Latest Anti-Hypertensive Drugs Market Share 2017- 2025 - Credence ResearchPosted by Ainsley Lewis on December 7th, 2017 The latest market report published by Credence Research, Inc. “Global Anti-Hypertensive Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the global anti-hypertensive drugs market was valued at USD 32,214.3 Mn in 2015, and is expected to reach USD 34,925.7 Mn by 2023, expanding at a CAGR of 1.2% from 2016 to 2023. Market Insights Hypertension is commonly observed chronic condition, in which the blood pressure is elevated abnormally both systolic and diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorder. The normal blood pressure level is 120-140mm Hg systolic and 60-90mm Hg diastolic any elevation above it is considered as hypertension. The major reason for the rise in prevalence of hypertension is lifestyle change, unhealthy food habits and demographic ageing. Anti-hypertensive drugs are used to reduce the level of blood pressure, different drug class of drugs with different mechanism of action exist in the market. The antihypertensive market is growing with increased patient pool especially geriatric population and extensive research and development for novel pipeline drug. The global antihypertensive market show robust growth in forecast period, but it face threat of genericization and increased competition due to patent expiry. Browse the full report Global Anti-Hypertensive Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023 report at http://www.credenceresearch.com/report/anti-hypertensive-drugs-market Anti-Hypertensive are categorized by drug class type as Diuretics, Angiotensin receptor blockers (ARBs), Angiotensin converting enzyme (ACE) inhibitors, Beta blockers, Alpha blockers, Calcium channel blockers, Renin inhibitors and Vasodilators. ACE inhibitor occupies the largest market share in terms of value due to mechanism of action and is preferred in geriatric population and diabetes patient as first line of treatment as antihypertensive drug. Beta blockers follow next in line due to preference of physician over diuretic, which are most commonly used. Based on the drug class type, the global Anti-hypertensive drugs market is segmented as follows: Diuretics Market Competition Assessment: Key players in the global Anti-Hypertensive drugs market are Novartis AG, Astra Zeneca, Pfizer Inc., Acetelion Ltd, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceutical, Bayer AG etc. Key Market Movements: Rising prevalence of hypertension due to various factors such as growing population, change in unhealthy lifestyle etc. Tonic Wine Market - http://www.credenceresearch.com/report/tonic-wine-market Inulin Market - http://www.credenceresearch.com/report/inulin-market About Us: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task. Contact: Name: Chris Smith Designation: Global Sales Manager Ph: 1-800-361-8290 Email: sales@credenceresearch.com Web: http://www.credenceresearch.com/ Like it? Share it!More by this author |